Fermented Mushrooms
30 new compounds
Lactic acid bacteria fermentation of shiitake mushrooms created 30 entirely new phenolic compounds absent in the fresh mushroom. The same microbial chemistry drives kombucha and other fermented mushroom beverages.
Ayar-Sumer et al., Foods, 2024
1 study
peer-reviewed comparison of mushroom vs. plain kombucha ever published
2 bacteria
Staphylococcus aureus and E. coli inhibited by reishi kombucha vs. plain
2024
systematic review confirmed enhanced bioactivity across fermented mushroom formats
Ayar-Sumer et al., Foods, 2024
Walk down the supplement aisle at any health food store and you'll find mushroom kombucha, mushroom-infused beer, and adaptogenic kefir. The labels make sweeping claims about gut health, immunity, and the synergy of medicinal fungi with fermentation. But the peer-reviewed research on this specific product category is thin enough that a single 2018 study by Sknepnek and colleagues in the International Journal of Medicinal Mushrooms constitutes the entire published head-to-head evidence comparing medicinal mushroom-enhanced kombucha to plain kombucha.
What that study found is genuinely interesting. What it can't tell us about human health outcomes is equally worth understanding. This article covers what the science shows about fermented mushroom beverages, why fermentation can transform certain mushroom compounds rather than just releasing them, and where the evidence honestly runs out. It's part of our broader series on how processing affects what mushrooms actually deliver.
Key Takeaways
- Reishi kombucha showed significantly higher antioxidant activity than standard kombucha and demonstrated antibacterial activity against Staphylococcus aureus and E. coli in the only published head-to-head comparison (Sknepnek et al., 2018)
- Lactic acid bacteria fermentation of shiitake created 30 entirely new phenolic compounds absent in unfermented mushrooms; fermentation synthesizes new bioactives, not just releases existing ones (Ayar-Sumer et al., 2024)
- A 2024 systematic review confirmed fermented mushroom products show enhanced antioxidant, antimicrobial, anti-glycemic, and immunomodulatory activity compared to unfermented equivalents across multiple species (Sivamaruthi et al., 2024)
- Fermented king oyster mushroom extract showed higher antioxidant activity and stronger macrophage activation than unfermented extract, with ergothioneine and beta-glucan content preserved or enhanced (Ulziijargal et al., 2012)
- The SCOBY's acidic pH (2.5-3.5) partially breaks down mushroom chitin cell walls, potentially improving the extractability of bound compounds, though this mechanism in a beverage context is based on fermentation chemistry rather than direct measurement
- No human clinical trials have tested any fermented mushroom beverage category; all published evidence is from in vitro food science
Reishi Kombucha vs. Plain Kombucha: The Only Published Comparison
Sknepnek and colleagues published the first and still only peer-reviewed study comparing medicinal mushroom-enhanced kombucha to standard kombucha in 2018.[1] The experimental setup was methodologically straightforward: a standard SCOBY fermented green tea with and without the addition of Ganoderma lucidum (reishi mushroom). After fermentation, the two beverages were tested side by side.
The reishi version outperformed plain kombucha on two measures.
First, antioxidant activity was significantly higher in the mushroom-enhanced version. This result points to something the industry often claims but rarely demonstrates: reishi's active compounds (the polyphenols, ganoderic acids, and phenolics) survived the fermentation process rather than being degraded by it. The beverage itself contained measurably more antioxidant capacity after reishi fermented alongside the SCOBY.
Second, the reishi kombucha showed antibacterial activity against Staphylococcus aureus and Escherichia coli. Standard kombucha does have some antimicrobial properties: the organic acids produced during fermentation (acetic acid, lactic acid, gluconic acid) create an inhospitable environment for certain pathogens. But the inhibition against these two specific bacterial strains went beyond what plain kombucha showed. Sknepnek's team attributed this to reishi's bioactive compounds contributing an antibacterial layer on top of standard kombucha's organic acid activity.
Being precise about what this establishes matters. These measurements were made in the beverage itself, in a food science laboratory. The study confirmed that reishi-enhanced kombucha is chemically different from plain kombucha in ways that are measurable and consistent with reishi's known bioactivity. It did not measure what happens when humans drink it: absorption, gut microbiome response, or any clinical endpoint. That evidence doesn't exist for this beverage category.
The practical question for consumers ("does it work?" in the sense of producing health effects) remains unanswered. The chemical question ("is it different?") has a clear yes.
What the SCOBY Does to Mushroom Compounds
The chemistry inside a kombucha SCOBY is more complex than most labels suggest. A SCOBY operates at pH 2.5 to 3.5, roughly the acidity of lemon juice, and contains a community of lactic acid bacteria, acetic acid bacteria, and various yeasts working in parallel. The fermentation runs 7 to 14 days at room temperature, producing organic acids, B vitamins, small amounts of ethanol (typically 0.5 to 2%), and carbon dioxide.
When medicinal mushrooms are added to this environment, three distinct processes operate simultaneously.
The first is chitin breakdown. Chitin is the structural polymer that makes mushroom cell walls tough. It's the same reason eating raw mushrooms or swallowing unextracted mushroom powder is relatively inefficient: the chitin cage keeps many bioactive compounds physically trapped, inaccessible to digestion. At pH 2.5 to 3.5, weak acid hydrolysis begins to weaken this cell wall matrix, releasing bound compounds that would otherwise pass through without being absorbed. This process is partial and slower than the high-temperature water extraction used in proper mushroom supplements, but it operates continuously over the full fermentation period. For context on why cell wall breakdown matters for bioavailability, see our article on beta-glucan absorption and why processing determines how much you absorb.
The second mechanism is enzymatic biotransformation. Lactic acid bacteria don't just release existing compounds. They convert them into new secondary metabolites through their own enzymatic machinery. Ayar-Sumer and colleagues demonstrated this precisely in 2024: after 24 hours of LAB fermentation of shiitake mushrooms, mass spectrometry identified 30 new phenolic compounds that were entirely absent in the pre-fermentation sample.[3] The LAB bacteria used the mushroom's existing phenolic structures as raw material for synthesis. Kombucha's microbial community includes LAB, which means the same biotransformation chemistry can operate when medicinal mushrooms are added to a kombucha brew.
The third mechanism involves reishi's fat-soluble triterpenoids: the ganoderic acids. Triterpenoids are the compounds that give reishi much of its functional distinction, and they typically require ethanol for efficient extraction. That's why alcohol-based double-extraction tinctures are the standard format for reishi supplements. During kombucha fermentation, the yeast produces small amounts of ethanol. Whether this trace alcohol meaningfully enhances ganoderic acid extraction into the beverage is biochemically plausible but not yet measured. This mechanism remains informed speculation based on fermentation chemistry, not a confirmed finding from the reishi kombucha literature.
Mushroom Beer: A Different Fermentation Chemistry
Beer fermentation uses a fundamentally different microbial system than kombucha. The primary organism is Saccharomyces cerevisiae yeast, working at higher temperatures (18-25°C for ales), with hop compounds in the wort, and producing a final alcohol content of 4-8% rather than kombucha's 0.5-2%. The fermentation is also faster, typically days to a few weeks, with less microbial diversity than a SCOBY community.
Adding medicinal mushrooms to beer creates a different set of interactions.
The higher alcohol content is the most meaningful difference. Ethanol is an excellent solvent for the fat-soluble triterpenoids that give reishi and other medicinal mushrooms much of their functional interest. At 4-8% alcohol, a mushroom-enhanced beer could extract and carry triterpenoid compounds that kombucha's 0.5-2% ethanol would only partially reach. This is the chemistry behind alcohol-based mushroom tinctures, the same principle scaled into a beverage format.
King oyster mushroom (Pleurotus eryngii) has received the most attention in the mushroom beer context. The 2024 systematic review by Sivamaruthi and colleagues synthesized food science research on P. eryngii added during beer brewing, noting effects on both yeast viability during fermentation and the sensory and functional profile of the final product.[2] Earlier work by Ulziijargal and colleagues had established that fermented P. eryngii extract showed significantly higher antioxidant activity than unfermented extract, with ergothioneine and beta-glucan content preserved or enhanced rather than degraded through the fermentation process.[4] Together these findings suggest that king oyster mushroom's functional compounds survive fermentation in a brewing context and may benefit from it.
What remains uncharted: whether the hop compounds in beer interact with mushroom phenolics in meaningful ways, and whether the bioavailability of mushroom compounds from a brewed product differs from a water or alcohol extract. Mushroom beer sits at the proof-of-concept stage in food science. The chemistry is interesting; the clinical data doesn't exist.
Vinegar, Kefir, and Other Fermented Mushroom Formats
The category extends well beyond kombucha and beer. The Sivamaruthi 2024 review covered a broader range of fermented mushroom products with varying levels of supporting evidence.[2]
Mushroom vinegar is a two-stage product: an initial alcoholic fermentation extracts and converts mushroom material, followed by a second fermentation where Acetobacter bacteria convert alcohol to acetic acid. The extended processing creates a highly acidic matrix with concentrated organic acids. Some food scientists have proposed that this double fermentation concentrates certain phenolic compounds. The initial alcohol stage extracts fat-soluble compounds, and the acidification stage may preserve or amplify water-soluble phenolics. The published data is sparse.
Kefir presents a different opportunity. Kefir grains contain dozens of bacterial species and yeasts, including substantial LAB populations. Adding mushroom material to kefir fermentation creates conditions for the same biotransformation chemistry that Ayar-Sumer documented: the potential for LAB to synthesize new phenolic compounds from mushroom precursors. The protein-rich dairy environment also interacts with mushroom polysaccharides in ways that could affect how compounds are delivered and absorbed. This area hasn't been systematically studied.
Lacto-fermented mushroom foods (more solid formats, like fermented shiitake pastes or mushroom miso-style products) represent another format with emerging research. These involve direct LAB fermentation of mushroom material on a substrate, closer to the SSF-style processing discussed in our article on solid-state fermentation and mushroom bioactivity than to beverage production. The distinction matters because solid-state fermentation with mushroom mycelium and LAB fermentation of mushroom material produce different compound profiles.
The consistent pattern across all formats: fermentation generally preserves functional mushroom compounds rather than degrading them, and in documented cases it enhances them. The depth of evidence decreases as you move away from kombucha.
Fermentation Creates New Compounds, Not Just Released Ones
The most counterintuitive finding in fermented mushroom research isn't about bioavailability. It's about biotransformation.
Bioavailability enhancement is the intuitive mechanism: fermentation breaks down cell walls, releasing compounds that would otherwise stay trapped. This is real and documented. But biotransformation is something more fundamental: fermentation creates compounds that did not exist in the original mushroom.
Ayar-Sumer's 2024 study demonstrated this with mass spectrometry precision.[3] Before LAB fermentation, they catalogued every detectable phenolic compound in fresh shiitake mushrooms. After 24 hours of LAB fermentation, 30 new phenolic compounds appeared. These weren't trace amounts of previously bound compounds now liberated; they were genuinely new molecular structures synthesized by the bacteria's enzymatic machinery, using the mushroom's phenolic scaffolding as raw material. The fermented shiitake contained compounds that the fresh mushroom had never contained.
This has specific implications for fermented mushroom beverages. When reishi is added to a kombucha SCOBY, the LAB in that SCOBY can potentially apply the same enzymatic conversion to reishi's phenolic compounds, producing new secondary metabolites not present in either the fresh reishi or the plain kombucha. What those compounds are in a beverage context, and whether they're biologically active in humans, hasn't been measured. The mechanism demonstrably exists in LAB fermentation of mushrooms. Its application to kombucha specifically is a logical extension that hasn't been directly tested.
This distinction also matters for understanding what kind of product a fermented mushroom beverage actually is. If fermentation creates compounds that exist in neither the mushroom alone nor the kombucha alone, then the fermented product is a chemically distinct entity, not just an additive combination of two familiar ingredients. For more on the specific enzymes and molecular pathways involved, see our article on mushroom biotransformation and how fermentation creates new compounds.
Whether you're comparing fermented versus unfermented mushroom products generally, or solid-state versus liquid fermentation methods, the biotransformation finding is what shifts fermented mushroom products from a convenience format into a potentially distinct functional category.
The Honest Evidence Audit
The marketing language around mushroom kombucha implies clinical health benefits that the research doesn't yet support. Being precise about the evidence gap is the only fair way to represent this category.
What the published research establishes: Reishi kombucha is measurably different from plain kombucha in antioxidant capacity and antibacterial activity, at the chemical level, in a controlled lab setting (Sknepnek 2018). Fermented mushroom products, across several species and formats, consistently show enhanced functional activity compared to unfermented equivalents in in vitro testing (Sivamaruthi 2024). LAB fermentation of mushrooms creates genuinely new bioactive compounds that standard analysis of fresh mushrooms wouldn't find (Ayar-Sumer 2024). Fermented P. eryngii extract shows enhanced antioxidant and immune-activating properties versus the unfermented version (Ulziijargal 2012).
What the research does not establish: Whether drinking a fermented mushroom beverage produces any measurable health effect in humans. Whether the compounds that differentiate mushroom kombucha from plain kombucha are absorbed at meaningful concentrations through the digestive system. Whether dose matters for any effect, and if so, what that dose looks like in a beverage format.
The gap exists not because the category is implausible. The food science genuinely points in a promising direction. But funded human clinical trials for functional beverages take years and substantial resources to execute. The product market has moved much faster than the research that would justify the claims being made.
The Sivamaruthi 2024 review's characterization of the field is appropriately calibrated: fermented mushrooms show "promising biological activities" that merit investigation in controlled human studies.[2] The food science is interesting and directionally consistent. The clinical validation doesn't exist yet. Both things are true, and neither cancels the other out.
The Bottom Line
Mushroom-enhanced fermented beverages show measurable functional advantages over plain fermented beverages in lab studies: reishi kombucha outperformed plain kombucha on antioxidant activity and demonstrated antibacterial properties not seen in standard kombucha, in the only published head-to-head comparison. Fermentation's ability to create genuinely new phenolic compounds through microbial biotransformation adds a mechanistic basis for taking this category seriously beyond simple bioavailability claims. Human clinical evidence is absent for every format in this category, and the gap between "interesting food science" and "proven health benefit" is real and has not yet been bridged.
Frequently Asked Questions
Sources & References
- 1. Source details for this reference are not yet available.
- 2. Source details for this reference are not yet available.
- 3. Source details for this reference are not yet available.
- 4. Source details for this reference are not yet available.